I tried to fill in the blanks but got lost among the factsMost stocks don't have on board the likes of Dr Peter Corr
Navigant wouldn't waste their time with 90% of ASX stocks
Unlike many stocks there's all that debt we don't have
A unique, effective, economical device, in a class of its own without direct competition, with significant benefit to half the global population, supported by professionals, meeting a massive unmet need, in the booming e-health sector
But in contrast to all the other asx stocks this is an absolute dud?
Following your logic of sp, sales & mc I should flee to the safety of blue chips; or punt on a driller or digger with 1/10 chance, or gamble on clinical trials, or put my money on a crypto with no vision of outcome
I'll play this game my way, with my perception of risk/reward
The sp/mc, which fortunately for me reflects in part a lack of hype which is attached to many currently trendy stocks, is an opportunity; the lack of sales & more importantly a deal so far makes this a good time to get in. The major positives mentioned are free; the sp is for our other product
(imo, dyor)
I suspect you're at the end of the line of .04 buyers, or a disgruntled former holder
Regardless, your downramping is just sad
The reason I don't report your lack of respect for hotcopper or fellow punters is so all can see your character.
